ArticleBlood cancer journal2023

Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study.

Dan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.